Navigation Links
Research on improvements in diagnosing and treating tuberculosis
Date:6/19/2012

This press release is available in Spanish.

Project PreDiCT-TB is being developed jointly by the Seventh Framework Program and the European pharmaceutical industry in the hopes of studying and improving the treatment of tuberculosis, and infectious disease that affects nearly nine million people throughout the world. The goal is to develop a set of pre-clinical trials ('in vitro' and 'in vivo') that will provide critical data for identifying decision-making criteria regarding the effectiveness of a given treatment, as well as to optimize the clinical studies of new combinations of drugs used to fight tuberculosis. "These data will, first, offer us an early evaluation of the efficiency of the combinations of drugs used to treat tuberculosis; and, second, they will allow us to optimize the clinical studies with patients", states the head of research at UC3M, Juan Jos Vaquero, from the Bioengineering and Aerospace Engineering Department.

The work being done at this Madrid university is mainly focused on the research and the development of new pre-clinical imaging technology, as well as on methods for processing and analyzing images for the evaluation and follow-up of illness in animal models. "We are going to develop new in vivo molecular image devices and also work on the synthesis of very specific probes for the biomarkers of this illness that have been identified by other partners in the consortium", explains Juan Jos Vaquero. "We are collaborating very closely with GlaxoSmithKline, whose laboratories are going to use our equipment, as well as with specialists from the Infectious Disease and Microbiology Service of Gregorio Maraon University General Hospital (Servicio de Enfermedades Infecciosas y Microbiologa del Hospital General Universitario Gregorio Maran - Madrid), who have a great deal of experience working with both the biology and the c
'/>"/>

Contact: Ana Herrera
oic@uc3m.es
Carlos III University of Madrid
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Grant program to spur new research on Alzheimers disease by encouraging collaboration
2. Research breakthrough: High brain integration underlies winning performances
3. IOC recognizes University of Calgary Sports Injury Research Prevention Centre
4. Scripps Research Institute announces five-year research collaboration with Bristol-Myers Squibb
5. Researchers identify need to sample multiple tumor zones in breast cancer
6. London researchers discover novel mechanism involved in key immune response
7. NTU researchers study little mighty creature for scientific breakthrough
8. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
9. UTMB researchers create powerful new method to analyze genetic data
10. Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
11. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research on improvements in diagnosing and treating tuberculosis
(Date:12/19/2014)... , Dec. 18, 2014  23andMe, Inc., the ... a study that pinpoints fine-scale differences in genetic ancestry ... . Since immigrants first arrived more ... States has served as a meeting place ... American history and the ongoing mixing of peoples with ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ... – with the clinical data to back it up," ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... student at Rensselaer Polytechnic Institute has learned very quickly ... medicine go down. In fact, with his invention, the ... most important and complex molecules in the human body, ... communicate with one another. Graduating senior Jeffery Martin has ...
... Mireya Correa, staff scientist at the Smithsonian Tropical Research ... Panama, received the Jos Cuatrecasas Medal for Excellence in ... the National Museum of Natural History and the United ... Botanical Symposium held at the museum. , Jos ...
... gas used as an agricultural pesticide, was introduced in ... and increase fruit yields. Agricultural production nurseries around the ... plants for export and domestic sales. In 2000, the ... and in 2005 MB was banned in the United ...
Cached Biology News:Undergrad has sweet success with invention of artificial Golgi 2Undergrad has sweet success with invention of artificial Golgi 3Smithsonian scientist receives 2008 Medal for Excellence in tropical botany 2Alternatives to ozone-depleting pesticide studied 2
(Date:12/24/2014)... Bethesda, MD (PRWEB) December 23, 2014 ... signed into law H.R. 83, the Omnibus and ... the first time, made hydrocephalus a condition eligible ... Research Programs (CDMRP) administered by the Department of ... conjunction with its allies on Capitol Hill, is ...
(Date:12/24/2014)... Diego, CA (PRWEB) December 23, 2014 ... where their Twitter followers can submit their #HolidayInTheLab ... themselves and their lab mates. , For those struggling ... lab mates, the Pipette.com Holiday in the Lab Contest ... Pipette.com Twitter followers to send pictures of ...
(Date:12/24/2014)... -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ) ... Application (CTA) with the United Kingdom,s ... approval to initiate clinical trials for the continued development ... on the Company receiving CTA regulatory approval, the Company ... the safety, tolerability and dose escalation of Anatabine Citrate ...
(Date:12/22/2014)... 22, 2014  Alternative Energy & Environmental Solutions, ... signed a letter of intent to acquire BioTechPharma ... patented a nanotechnology-based development platform used to create ... rapid on-site collection and testing to identify infectious ... in an immediate, non-invasive and cost-effective manner. ...
Breaking Biology Technology:Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3ALNE Announces Intention To Acquire BioTechPharma 2
... Mylan Inc. (Nasdaq: MYL ) today announced ... it holds a 71.2% controlling interest, has been selected ... projects as the primary supplier of five antiretroviral (ARV) ... has been selected as the primary supplier of seven ...
... DIEGO, April 20 Trius Therapeutics, Inc. today announced ... H. Batts, MD, FACP, FIDSA, and G. Ralph Corey, ... group of anti-infective thought leaders. Dr. Batts is ... and the Chief of Infectious Diseases at its ...
... -- Data presented at 100th Annual Meeting of the ... 19 Researchers from Dendreon Corporation (Nasdaq: ... Treatment and Early Cancer Treatment) or P-11 Phase 3 ... responses that are durable and can be maintained following ...
Cached Biology Technology:Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments 2Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments 3Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board 2Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 2Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 3Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 4Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 5
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
... raised against a partial recombinant NFKBIB. ... 145 a.a) partial recombinant protein with GST tag. ... Accession: BC015528 ... OMIM: 604495, GeneID: ...
... Perm/Wash Buffer I can be used in ... to permeabilize cells and to serve as ... Because saponin-mediated cell permeabilization is a reversible ... cells in the presence of saponin during ...
Mouse monoclonal antibody raised against a partial recombinant ACTN4. NCBI Entrez Gene ID = ACTN4...
Biology Products: